Washington, DC, United States of America

Joseph Melinger

This inventor holds 1 USPTO granted patent. Top assignee: USA as Represented by Secretary of the Navy. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joseph Melinger: Innovator in Phosphoramidite Technology

Introduction

Joseph Melinger is a notable inventor based in Washington, DC. He has made significant contributions to the field of chemistry, particularly in the development of innovative phosphoramidites. His work has implications for various applications, showcasing his expertise and dedication to advancing technology.

Latest Patents

Joseph Melinger holds a patent titled "Indodicarbocyanine Phosphoramidites with Bathochromically Shifted Absorption and Emission, and Tunable Hydrophobicity." This patent highlights his innovative approach to creating compounds that can be utilized in various scientific applications. He has 1 patent to his name, reflecting his commitment to research and development.

Career Highlights

Melinger works for the United States as represented by the Secretary of the Navy. His role involves applying his expertise in chemistry to support the Navy's technological advancements. His contributions are vital to the ongoing research and development efforts within the organization.

Collaborations

One of his notable collaborators is William B. Knowlton. Together, they have worked on projects that leverage their combined expertise in chemistry and technology. Their partnership exemplifies the collaborative spirit that drives innovation in scientific research.

Conclusion

Joseph Melinger's work in phosphoramidite technology demonstrates his significant impact on the field of chemistry. His innovative patent and collaboration with esteemed colleagues highlight his dedication to advancing scientific knowledge and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…